AstraZeneca PLC is 49.3x more valuable than Liquidia Corp by market capitalization ($286.27 B vs $5.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LQDA | AZN |
|---|---|---|
| Market cap | $5.80 B | $286.27 B |
| US-listed rank | #1290 | #45 |
| Revenue (latest FY) | $158.32M | - |
| Net income (latest FY) | -$68.92M | - |
| Net margin | -43.5% | - |
| SEC filings | 628 | 1,004 |
AstraZeneca PLC is 49.3x more valuable than Liquidia Corp by market capitalization ($286.27 B vs $5.80 B).
Full pages: Liquidia Corp and AstraZeneca PLC, or browse the full rankings.